US Patent Issued to ImmunEdge, The Board of Trustees of the Leland Stanford Junior University on Sept. 8 for "Method of increasing an immune response to a cancer by administering an antibody which inhibits erythropoietin receptor activation" (California Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,240, issued on Sept. 8, was assigned to ImmunEdge Inc. (Redwood City, Calif.) and The Board of Trustees of the Leland Stanford Junior University (Stanford, Calif.).

"Method of increasing an immune response to a cancer by administering an antibody which inhibits erythropoietin receptor activation" was invented by Bo Yu (Mountain View, Calif.), Edgar G. Engleman (Atherton, Calif.), Xiangyue Zhang (Sunnyvale, Calif.) and David Kung-Chun Chiu (Mountain View, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides anti-EPOR antibodies, anti-EPO antibodies, and fragments thereof that specifically bind to the hetero-EPOR or ho...